Copyright
©The Author(s) 2022.
World J Gastroenterol. Sep 7, 2022; 28(33): 4823-4833
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4823
Published online Sep 7, 2022. doi: 10.3748/wjg.v28.i33.4823
Figure 1 Time based on biologic therapy.
A: Treatment discontinuation; B: Adverse event; C: Infection.
- Citation: Hahn GD, LeBlanc JF, Golovics PA, Wetwittayakhlang P, Qatomah A, Wang A, Boodaghians L, Liu Chen Kiow J, Al Ali M, Wild G, Afif W, Bitton A, Lakatos PL, Bessissow T. Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study. World J Gastroenterol 2022; 28(33): 4823-4833
- URL: https://www.wjgnet.com/1007-9327/full/v28/i33/4823.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i33.4823